tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Barclays sees ‘significant potential’ in CytomX’s CX-2051 despite safety event
PremiumThe FlyBarclays sees ‘significant potential’ in CytomX’s CX-2051 despite safety event
1M ago
CytomX trial ongoing despite grade five event, says Oppenheimer
Premium
The Fly
CytomX trial ongoing despite grade five event, says Oppenheimer
1M ago
CytomX Therapeutics Updates on CX-2051 Phase 1 Study
Premium
Company Announcements
CytomX Therapeutics Updates on CX-2051 Phase 1 Study
1M ago
CytomX Therapeutics reports Q2 EPS 0c, consensus (6c)
PremiumThe FlyCytomX Therapeutics reports Q2 EPS 0c, consensus (6c)
2M ago
CytomX Therapeutics files $250M mixed securities shelf
Premium
The Fly
CytomX Therapeutics files $250M mixed securities shelf
2M ago
CytomX Therapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
CytomX Therapeutics initiated with an Outperform at Oppenheimer
2M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
Premium
The Fly
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
4M ago
CytomX Therapeutics price target raised to $5 from $2.50 at Piper Sandler
Premium
The Fly
CytomX Therapeutics price target raised to $5 from $2.50 at Piper Sandler
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100